4-[5-[3-(2-methyl-4-pyridinyl)pyrazol-1-yl]-2-(morpholin-4-ylmethyl)thieno[3,2-b]pyridin-7-yl]morpholine
C25H28N6O2S — CID 169032693
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[5-[3-(2-methyl-4-pyridinyl)pyrazol-1-yl]-2-(morpholin-4-ylmethyl)thieno[3,2-b]pyridin-7-yl]morpholine
4-[5-[3-(2-methyl-4-pyridinyl)pyrazol-1-yl]-2-(morpholin-4-ylmethyl)thieno[3,2-b]pyridin-7-yl]morpholine (PubChem CID 169032693) has the molecular formula C25H28N6O2S and a molecular weight of 476.61 g/mol. Its IUPAC name is 4-[5-[3-(2-methyl-4-pyridinyl)pyrazol-1-yl]-2-(morpholin-4-ylmethyl)thieno[3,2-b]pyridin-7-yl]morpholine.
Molecular Properties
| Compound Name | 4-[5-[3-(2-methyl-4-pyridinyl)pyrazol-1-yl]-2-(morpholin-4-ylmethyl)thieno[3,2-b]pyridin-7-yl]morpholine |
|---|---|
| PubChem CID | 169032693 |
| Molecular Formula | C25H28N6O2S |
| Molecular Weight | 476.61 g/mol |
| Exact Mass | 476.20 |
| IUPAC Name | 4-[5-[3-(2-methyl-4-pyridinyl)pyrazol-1-yl]-2-(morpholin-4-ylmethyl)thieno[3,2-b]pyridin-7-yl]morpholine |
| SMILES | Cc1cc(-c2ccn(-c3cc(N4CCOCC4)c4sc(CN5CCOCC5)cc4n3)n2)ccn1 |
| InChI | InChI=1S/C25H28N6O2S/c1-18-14-19(2-4-26-18)21-3-5-31(28-21)24-16-23(30-8-12-33-13-9-30)25-22(27-24)15-20(34-25)17-29-6-10-32-11-7-29/h2-5,14-16H,6-13,17H2,1H3 |
| InChIKey | SBJSRHPOZXAASI-UHFFFAOYSA-N |
| XLogP | 3.52 |
| TPSA | 68.54 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 476.61 |
| LogP ≤ 5 | 3.52 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 169032693 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.